Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Thursday morning. Here’s what you need to know. Omnicell beat analysts’ revenue expectations by 4.9% last ...

Omnicell (OMCL) shares recently dipped about 2% over the past day, sparking renewed curiosity about its valuation, especially after a volatile stretch for healthcare technology stocks. Investors may ...

On Tuesday, Benchmark analysts maintained a Buy rating on Omnicell stock (NASDAQ:OMCL) with a consistent price target of $62.00 as the company approaches its earnings release scheduled for February 6.

The company continues to benefit from demand for its next-generation healthcare tech offerings. Revenue for Omnicell in its third quarter amounted to $311 million, notching the company a 10% gain in ...

Omnicell, Inc. OMCL is well poised for growth in coming quarters owing to strong execution of strategies, disciplined cost management and revenue timing. An increase in Omnicell’s service revenues ...

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have lost about 0.4% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the second quarter 2025, before market open on Thursday, ...

Fintel reports that on November 3, 2023, Wells Fargo upgraded their outlook for Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight. As of October 31, 2023, the average one-year price target for ...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the third quarter 2025, before market open on Thursday, ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced OmniSphere, a ...